Review articleSex differences in depression: Insights from clinical and preclinical studies
Section snippets
Sex differences in clinical presentation, comorbidities, and antidepressant efficacy
Depression is a heterogeneous disorder whereby clinical presentation and symptomology varies between affected individuals (Rush, 2007). There is evidence that biological sex is a factor that can explain at least some of the variability in depression presentation and comorbidities. For example, various reports indicate that compared to men, women with depression are more likely to experience higher symptom severity (Marcus et al., 2008, Marcus et al., 2005), and the sexes show differences in the
Potential sex differences in the etiology and pathophysiology of depression
Depression is a complex disorder with substantial heterogeneity in etiology and pathophysiology. Several theories have been posited to explain the mechanisms underlying depression, including dysfunction or alterations in monoamine neurotransmitter systems (Delgado, 2000, Hirschfeld, 2000), the glutamatergic system (Sanacora et al., 2012), stress response systems (Gold, 2015), sex steroids (Bloch et al., 2003), neuropeptides (Kormos and Gaszner, 2013, Morales-Medina et al., 2010) neuroplasticity
Sex differences in anatomical brain abnormalities in depression
Individuals with depression present with anatomical abnormalities and dysregulated network connectivity in limbic regions (Drysdale et al., 2017, Greicius et al., 2007, Koolschijn et al., 2009, Lorenzetti et al., 2009, Schmaal et al., 2016). Morphological alterations to the hippocampus are perhaps the most extensively studied in relation to depression, with several reports of reduced hippocampal volume, an effect which is corroborated by meta-analyses (McKinnon et al., 2009, Schmaal et al., 2016
Sex differences in the effects of stress exposure or antidepressant treatment on adult hippocampal neurogenesis and dendritic remodeling
The hippocampus maintains the ability to produce new neurons throughout life in many species including humans (Boldrini et al., 2018, Eriksson et al., 1998, Gould et al., 1999), and evidence points to a role of neurogenesis in emotional processing (Anacker and Hen, 2017) and the neuroendocrine stress response (Surget et al., 2011). Reduced hippocampal neurogenesis is observed in animal models of depression (Bessa et al., 2009, Brummelte and Galea, 2010a, Brummelte and Galea, 2010b, David et
Sex difference in the transcriptional signature of depression
The success of genome-wide association studies (GWAS) in identifying genetic loci that significantly contribute to depression susceptibility has been generally limited (Consortium, 2015, Flint and Kendler, 2014, Hyde et al., 2016), highlighting the genetic heterogeneity of the disorder, and the role of environmental influences. On the other hand, there is emerging evidence indicating that depression-related changes in gene expression are sex-specific (Gray et al., 2015, Labonté et al., 2017,
Sex differences in immune dysregulation in depression and its models
There is ample evidence in support of the involvement of the immune system in depression (reviewed in Miller and Raison, 2016), and a subpopulation of individuals with depression display increased circulating concentrations of pro-inflammatory markers (meta-analyses: (Dowlati et al., 2010, Haapakoski et al., 2015)), and elevated markers of neuroinflammation (Rao et al., 2010, Setiawan et al., 2015, Steiner et al., 2008). Further, there is no shortage of evidence linking inflammation to
Sex hormones in depression and its treatment
Sex differences in depression point to a role of sex hormones in the disease mechanisms. Indeed, both androgens in men and estrogens in women have been implicated in depression and its treatment. In men, hypogonadism is associated with depression (McIntyre et al., 2006, Shores et al., 2005, Westley et al., 2015), and testosterone replacement therapies show some efficacy in alleviating depression, particularly in hypogonadal men (Seidman and Rabkin, 1998, Shores et al., 2009, Zarrouf et al., 2009
Depression during pregnancy and the postpartum period: female-unique factors in the susceptibility for depression
Pregnancy and motherhood place unique physiological and behavioral demands on the females of most mammalian species, including humans. The peripartum period also represents a time of increased susceptibility to mood disorders in a women's life, with an estimated 15% of women developing depression during the perinatal period (O’Hara and Swain, 1996). Below, we discuss issues surrounding the presentation, time course, and treatment of perinatal depression (PND). We also review neurobiological
Distinguishing postpartum depression from major depression
Currently, the DSM-5 defines depression in mothers under Major Depressive Disorder (MDD), with peripartum onset as a specifier; this includes all the diagnostic criteria of MDD but occurring during pregnancy or within the first four weeks of giving birth (American Psychiatric Association, 2013). However, there are several issues with this definition. First, this definition does not categorize depression during antepartum versus during the postpartum as separate subtypes of MDD, and it does not
Neurobiology of motherhood & PPD
During pregnancy, total brain volume shrinks by 8% and returns to pre-conception volume within 6 months postpartum (Oatridge et al., 2002). A recent study showed pre- to post-pregnancy reductions in gray matter volume in areas such as the anterior cingulate cortex, bilateral temporal cortex, inferior frontal cortex, and the hippocampus, and these reductions were correlated with maternal-infant attachment (Hoekzema et al., 2017). The reductions in gray matter volume were still evident 2 years
Issues surrounding PPD treatment
As in the case of MDD, mothers suffering from depression during pregnancy and postpartum are also prescribed antidepressants such as SSRIs. However, there is emerging clinical evidence indicating that these prescribed antidepressants have limited efficacy during gestation or in the postpartum (systematic review: De Crescenzo et al., 2014). One clinical trial found that SSRI treatment reduced depressive scores 4 weeks into the intervention period in comparison to counseling, but this effect was
Conclusions
It is evident from the preceding review of the literature that there are notable sex differences in depression-related gene expression, neuroplasticity, and immune signatures; these differences may account for disparities in prevalence and pathoetiology of the disease between men and women. There are sex differences reported in other biomarkers of depression (e.g. BDNF, nerve growth factor, serotonin, and dopamine), and in genetic polymorphisms associated with risk for depression, but these are
References (270)
- et al.
The contribution of hypothalamic neuroendocrine, neuroplastic and neuroinflammatory processes to lipopolysaccharide-induced depressive-like behaviour in female and male rats: Involvement of glucocorticoid receptor and C/EBP-β
Behav. Brain Res.
(2015) - et al.
Toward validation of atypical depression in the community: results of the Zurich cohort study
J. Affect. Disord.
(2002) - et al.
HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients
Psychoneuroendocrinology
(2009) - et al.
Endocrine factors in the etiology of postpartum depression
Compr. Psychiatry
(2003) - et al.
Differential effects of stress on microglial cell activation in male and female medial prefrontal cortex
Brain. Behav. Immun.
(2016) - et al.
Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats
Neuroscience
(2010) - et al.
Chronic corticosterone during pregnancy and postpartum affects maternal care, cell proliferation and depressive-like behavior in the dam
Horm. Behav.
(2010) - et al.
High post-partum levels of corticosterone given to dams influence postnatal hippocampal cell proliferation and behavior of offspring: a model of post-partum stress and possible depression
Horm. Behav.
(2006) - et al.
Sex differences in the antidepressant-like effects of ketamine
Neuropharmacology
(2013) - et al.
Testosterone and imipramine have antidepressant effects in socially isolated male but not female rats
Horm. Behav.
(2012)
Oxytocin and HPA stress axis reactivity in postpartum women
Psychoneuroendocrinology
Early motherhood in rats is associated with a modification of hippocampal function
Psychoneuroendocrinology
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression
Neuron
Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): a systematic review of randomized clinical trials
J. Affect. Disord.
Monoamine neurotransmitters and metabolites during the estrous cycle, pregnancy, and the postpartum period
Pharmacol. Biochem. Behav.
A meta-analysis of cytokines in major depression
Biol. Psychiatry
Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms
Brain. Behav. Immun.
Sex differences in cell proliferation, cell death and defensive behavior following acute predator odor stress in adult rats
Brain Res.
Sex and age differences in the antidepressant-like effect of fluoxetine in the forced swim test
Pharmacol. Biochem. Behav.
Factors associated with onset timing, symptoms, and severity of depression identified in the postpartum period
J. Affect. Disord.
Role of serotonin transporter changes in depressive responses to sex-steroid hormone manipulation: a positron emission tomography study
Biol. Psychiatry
Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression
Behav. Brain Res.
Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress
Neuroscience
Chronic stress effects on dendritic morphology in medial prefrontal cortex: sex differences and estrogen dependence
Neuroscience
Perinatal fluoxetine increases hippocampal neurogenesis and reverses the lasting effects of pre-gestational stress on serum corticosterone, but not on maternal behavior, in the rat dam
Behav. Brain Res.
Voluntary running influences the efficacy of fluoxetine in a model of postpartum depression
Neuropharmacology
Role of estradiol withdrawal in ‘anhedonic’ sucrose consumption: a model of postpartum depression
Physiol. Behav.
Adult hippocampal cell proliferation is suppressed with estrogen withdrawal after a hormone-simulated pregnancy
Horm. Behav.
Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus
Biol. Psychiatry
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Brain. Behav. Immun.
The effects of gestational stress and selective serotonin reuptake inhibitor antidepressant treatment on structural plasticity in the postpartum brain – a translational model for postpartum depression
Horm. Behav.
Hormonal changes in the postpartum and implications for postpartum depression
Psychosomatics
Gender and depression in men
Clin. Psychol. Sci. Pract.
Treatment resistant depression: a multi-scale, systems biology approach
Neurosci. Biobehav. Rev.
Phenotypic differences between pregnancy-onset and postpartum-onset major depressive disorder
J. Clin. Psychiatry
DSM-5
Am. J. Psychiatry
Adult hippocampal neurogenesis and cognitive flexibility — linking memory and mood
Nat. Rev. Neurosci.
Gender differences in depression: Epidemiological findings from the European DEPRES I and II studies
Eur. Arch. Psychiatry Clin. Neurosci.
A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression
BMJ
Stress sensitivity and the development of affective disorders
Horm. Behav.
Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders
Front. Neuroendocrinol.
Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine
J. Affect. Disord.
The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling
Mol. Psychiatry
Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review
Gend. Med.
Sex differences in the peripheral immune system in patients with depression
Front. Psychiatry
The antidepressant effect of running is associated with increased hippocampal cell proliferation
Int. J. Neuropsychopharmacol.
Running has differential effects on NPY, opiates, and cell proliferation in an animal model of depression and controls
Neuropsychopharmacology
Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
J. Clin. Psychiatry
The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression
J. Clin. Psychiatry
Effects of gonadal steroids in women with a history of postpartum depression
Am. J. Psychiatry
Cited by (222)
Sex differences in the association between peripheral inflammation and melancholia symptoms
2024, Psychiatry Research CommunicationsAssociations between somatic symptoms and remission of major depressive disorder: A longitudinal study in China
2024, Journal of Psychiatric ResearchDistinctive intrinsic functional connectivity alterations of anterior cingulate cortex subdivisions in major depressive disorder: A systematic review and meta-analysis
2024, Neuroscience and Biobehavioral ReviewsNovel rapid treatment options for adolescent depression
2024, Pharmacological Research